JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
84 hedge funds and large institutions have $64.1M invested in Jounce Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-1
Holders Change %
-1.18%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
21
Reduced
20
Closed
21
Calls
$136K
Puts
$10K
Net Calls
+$126K
Net Calls Change
+$123K
